Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis

Journal of Endocrinological Investigation

Volumn 39, Issue 10, 2016, Pages 1167-1178

  Liu, S ^a   Liu, Q ^a   Cheng, X ^a   Luo, Y ^a   Wen, Y ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Gonadotropin releasing hormone analogue; Growth hormone; Idiopathic central precocious puberty; Meta analysis

Indexed keywords

BUSERELIN; DESLORELIN; GLUCOSE; GONADORELIN; GONADORELIN DERIVATIVE; GROWTH HORMONE; INSULIN; LEUPRORELIN; SOMATOMEDIN C; TRIPTORELIN; HUMAN GROWTH HORMONE;

ARTICLE; BIBLIOGRAPHIC DATABASE; BODY HEIGHT; BONE MATURATION; CHINESE BIOMEDICAL DATABASE; CNKI DATABASE; COCHRANE LIBRARY; COMBINATION DRUG THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; EBSCO DATABASE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH RATE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY; IDIOPATHIC DISEASE; INSULIN BLOOD LEVEL; MEDLINE; META ANALYSIS; MONOTHERAPY; OVARY CYST; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVID DATABASE; PRECOCIOUS PUBERTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; THYROID DISEASE; VIP DATABASE; WANFANG DATABASE; WEB OF SCIENCE; AGONISTS; PUBERTY, PRECOCIOUS; SAFETY;

DRUG THERAPY, COMBINATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; PUBERTY, PRECOCIOUS; SAFETY;

EID: 84987897213     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0486-9     Document Type: Article

References (40)

1. Cesario SK, Hughes LA (2007) Precocious puberty a comprehensive review of literature. J Obstet Gynecol Neonatal Nurs 36(3):263–274
2. Carel JC, Chaussain JL (1999) Gonadotropin releasing hormone agonist treatment for central precocious puberty. Horm Res 51(Suppl3):64–69
3. Volta C, Regazzi C, Ndaka J, Vitale R, Bernasconi S (2005) Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty. Acta Biomed 76(2):73–78
4. Ministry of health in people’s republic of china (2011) Precocious puberty guidelines (for trial implementation). Chin J Child Health Care 19(4):390–392
5. Chen M, Eugster EA (2015) Central precocious puberty: update on diagnosis and treatment. Paediatr Drugs 17(4):273–281
6. Heger S, Sippell WG, Partsch CJ (2005) Gonadotropin-releasing hormone analogue treatment for precocious puberty twenty years of experience. Endocr Dev 8:94–125
7. Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, Chrousos GP, Dacou-Voutetakis C (2010) The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 95(1):109–117
8. Poomthavorn P, Suphasit R, Mahachoklertwattana P (2011) Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol 27(8):524–528
9. Kohn B, Julius JR, Blethen SL (1999) Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience. Pediatrics 104(4 pt 2):1014–1018
10. Oostdijk W, Drop SLS, Odink RJH, Hummelink R, Partsch CJ, Sipell WG (1991) Long-term results with a slow-release gonadotrophin-release hormone agonist in central precocious puberty. Acta Pediatr Stand 372(Suppl):39–45
11. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G, Battini R (1993) Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin-releasing hormone analogue treatment. Acta Pediatr 82(3):261–266
12. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G, Battini R, Pucarelli I, Segni M, Franchi G (1995) Effect of combined treatment with gonadotropin releasing analogue and growth hormone in patients with precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 84(3):299–304
13. Tatò L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M (1995) Use of combined GnRH agonist and hGH therapy for better attaining the goals in precocious puberty treatment. Horm Res 44(Suppl 3):49–54
14. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerrone F (1999) Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Metab 84(2):449–452
15. Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM (2003) Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 16(7):1005–1010
16. Lee PA (2003) The effects of manipulation of puberty on growth. Horm Res 60(Suppl 1):60–67
17. Li P, Li Y, Yang CL (2014) Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis. Medicine 93(27):1–8
18. Lee PA (1994) Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 148(4):369–376
19. Ng SM, Kumar Y, Cody D (2003) Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 88:414–418
20. Brauner R, Bashamboo A, Rouget S (2010) Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls. PLoS ONE 5(6):e11282
21. Frindik JP, Baptista J (1999) Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study. Pediatrics 104(4):1000–1004
22. Cappa M, Iughetti L, Loche S, Maghnie M, Vottero A (2015) Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the genesis clinical study. J Endocrinol Invest 98(Supplement s1):1–11
23. Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic review of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. http://www.cochrane-handbook.org
24. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716
25. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, JonesD R (2000) Empirical assessment of effect of publication bias on meta-analyses. BMJ 320:1574–1577
26. Zhao X, Zhang Q, Gao XJ (2011) Effect of combined treatment of minidose estrogen and gonadotropin releasing hormone analogues for children with idiopathic central precocious puberty. J Xin Xiang Med Coll 28(4):454–457
27. Wei QX, Zhou ZH, Li Y (2003) Observation of Combined therapy with GnRH analog plus growth hormone in central precocious puberty. Med Inf 16(6):328–329
28. Fang LJ, Shen YN (2004) Effects of gonadotropin-releasing hormone analog and growth hormone therapy on final height in girls with central precocious puberty. Chin J Mod Pediatr 1(4):320–322
29. Yan X, Teng YQ, Lu QY (2007) Clinical evaluation of precocious puberty of later stage treated with growth hormonal. Chin J Primary Med Pharm 14(5):819–820
30. Luo XD (2015) Clinical effect of GnRHa combined with recombinant human growth hormone (rhGH) in the treatment of idiopathic central precocious puberty (ICPP) in girls. China Mod Med 22(3):107–109
31. Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S (1996) Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab 81(3):948–951
32. Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM (2000) Combined therapy with GnRH analog plus growth hormone in central precocious puberty: a further contribution. J Pediatr Endocrinol Metab 13(Suppl 1):811–820
33. Li YH, Zhu SY, Ma HM, Su Z, Chen HS, Chen QL, Gu YF, Du ML (2013) Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth. Zhonghua Er Ke Za Zhi 51(11):807–812
34. Wang CL, Liang L, Liu PN, Jin XJ, Chen LQ, Yang F, Lian Q, Chen RM (2014) Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty. Zhongguo Dang Dai Er Ke Za Zhi 16(1):25–30
35. Zhu SY, Chen HS, Ma HM, Li YH, Pan SN, Su GuYF, Du ML (2009) Growth effect of stanazolol in girls with central idiopathic precocious puberty treated with GnRH analogue. China J Child Health Care 17(1):51–53
36. Zheng PM, Su Z, Ma HM, Du ML, Chen QL, Li YH, Chen HS (2011) Final adult height in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue and growth hormone. Chin J Endocrinol Metab 27(4):287–291
37. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L (2002) Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156(3):230–240
38. Bryant J, Baxter L, Cave CB, Milne R (2007) Recombinant growth hormone for idiopathic short stature in children and adolescents (review). Cochrane Database Syst Rev 18(3):CD004440
39. http://ichgcp.net/6-clinical-trial-protocol-and-protocol-amendments
40. Bryant J, Cave C, Mihaylova B, Chase D, McIntyre L, Gerard K, Milne R (2002) Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 18(6):1–168